Updates of our initial investment reports were recently released. These reports cover the period of 2005 to 2010. The survivorship report shows a gradual year-upon-year increase in research investment from 2005 to 2010, peaking in 2010 at $15.8M largely due to increased investment in targeted funding and equipment/infrastructure funding. There is evidence that the number of researchers working in survivorship research increased over the six years covered. Investment in palliative and end-of-life care cancer research also benefited from significant targeted investment, specifically a major initiative from the Canadian Institutes of Health Research (CIHR). The increased investment from non-targeted programs in 2009, which was sustained in 2010, suggests that CIHR’s targeted initiative was successful in building research capacity in the palliative and end-of-life care areas. To access the reports, click here.
With funding from the Canadian Partnership Against Cancer, the Ontario Institute for Cancer Research (OICR) has been selected to develop the Coordinating Centre for the Canadian Cancer Clinical Trials Network, the leadership and administrative hub of the still-to-be-created pan-Canadian clinical trials network. Dr. Janet Dancey, Program Director of the High Impact Clinical Trials Program at OICR will lead the Coordinating Centre. The NCIC-Clinical Trials Group and N2 (Network of Networks) are collaborating with OICR on the project. Read more...
Our new report shows that after a steady climb in research investment peaking in 2009 at $548M, the cancer research investment in 2010 dipped slightly to $536M. There was, however, a continued rise in 2010 in the investment in operating grants (direct research support) that were focused on specific cancer sites and/or research areas. To access the full report, click here.
Registration for the Canadian Cancer Research Conference is now open. The deadline for registration is October 14, 2013. For more information about registration or to register, please click here.